BIO-IRBESARTAN

biomed pharma🇨🇦 Health Canada

Approval Id: 4a50648afe2c6c89
Drug Approval Canada Name: BIO-IRBESARTAN
Product Name: BIO-IRBESARTAN
Status: Cancelled Post Market
Status Date: 2022-07-19
Original Market Date: 2016-08-17
Din: 02446154
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:32.08
Atc Original: C09CA04 IRBESARTAN
Atc Name: c 09 ca 04
Aig Number: 0131700002
Company Name: biomed pharma
Company Address: 1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8

IRBESARTAN

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4a50648afe2c6c89

Type

Standard